Frank A. Scappaticci

Associate Group Medical Director at Genentech , Inc.

Location:
1 DNA Way, South San Francisco, California, United States
Company:
Genentech , Inc.
HQ Phone:
(650) 225-1000
Wrong Frank Scappaticci?

Last Updated 12/15/2015

General Information

Employment History

Position In Clinical Science Leader  - F. Hoffmann-La Roche Ltd.

Education

biochemistry , Yale University

M.D.  - 

medical and graduate degrees  - Roswell Park

undergraduate degree  - biochemistry , Yale University

Web References  

Speakers | eucraf - The European Centre for Regulatory Affairs | Speakers |

Frank A. Scappaticci
Genentech Inc. / Roche Frank A. Scappaticci, MD, PhD is a clinical oncologist and hematologist working at Genentech / Roche. Dr. Scappaticci obtained his undergraduate degree at Yale University in biochemistry. Subsequently, he trained at the University at Buffalo / Roswell Park where he obtained his medical and graduate degrees. He completed his internship and residency in Internal Medicine at the University of Pennsylvania. Following this, he obtained his Medical Center. After a short period on faculty at Stanford and the University of California / Davis he joined Genentech approximately 9 years ago and has been working on late stage clinical trial development for Avastin. He had led numerous filings for Avastin that eventually led to approval for Avastin in colorectal, non-small cell lung, and renal cancers. Recently, Dr. Scappaticci was appointed as the clinical science leader on the Roche Biologics Task force.

Read More
ORIENTED Happy Hours - Get oriented to the Orient!

Frank Scappaticci
Associate Group Medical Director, Genentech

Read More
http://www.visiongain.com/Conference/332/10th-Biosimilars-Americas

• Frank A. Scappaticci, MD, PhD, Clinical Science Leader, F. Hoffmann-La Roche Ltd
Frank A. Scappaticci, MD, PhD Clinical Science Leader F. Hoffmann-La Roche Ltd Frank A. Scappaticci, MD, PhD Frank A. Scappaticci, MD, PhD Clinical Science Leader F. Hoffmann-La Roche Ltd Frank A. Scappaticci, MD, PhD is a clinical oncologist & hematologist working at Genentech / Roche. Dr. Scappaticci obtained his undergraduate degree at Yale University in biochemistry. Subsequently, he trained at the University at Buffalo / Roswell Park where he obtained his medical and graduate degrees. He completed his internship and residency in Internal Medicine at the University of Pennsylvania. Following this, he obtained his Medical Oncology and Hematology training at Stanford University Medical Center. After a short period on faculty at Stanford and the University of California / Davis, he joined Genentech approximately 8 years ago and has been working on late stage clinical trial development for Avastin. He has led numerous filings for Avastin that eventually led to approval for Avastin in colorectal, non-small cell lung, and renal cancers. Recently, Dr. Scappaticci was appointed as the clinical science leader on the Roche Biosimilar Task force.

Read More

Browse ZoomInfo’s Directories